CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C01704 | BRD-A69951442 | dexamethasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C01705 | BRD-A69960130 | bromocriptine | ADRA2A; ADRA2B; ADRA2C; DRD1; DRD2; DRD3; DRD4; DRD5; HTR1A; HTR1B; HTR1D; HTR2A; HTR2B; HTR2C | Dopamine receptor agonist | -- | Details |
| C01706 | BRD-A70083328 | secnidazole | -- | -- | -- | Details |
| C01707 | BRD-A70099008 | BRD-A70099008 | -- | -- | -- | Details |
| C01708 | BRD-A70150975 | hydroxyl | -- | -- | -- | Details |
| C01709 | BRD-A70155556 | lovastatin | HMGCR | HMGCR inhibitor | -- | Details |
| C01710 | BRD-A70167453 | BRD-A70167453 | -- | -- | -- | Details |
| C01711 | BRD-A70180851 | CCT-244747 | -- | -- | -- | Details |
| C01712 | BRD-A70182876 | azapropazone | PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C01713 | BRD-A70268693 | PG-9 | -- | -- | -- | Details |
| C01714 | BRD-A70311631 | BRD-A70311631 | -- | -- | -- | Details |
| C01715 | BRD-A70407468 | PSB-36 | ADORA1 | Adenosine receptor antagonist | -- | Details |
| C01716 | BRD-A70449690 | forskolin | ADCY2 | Adenylyl cyclase activator | -- | Details |
| C01717 | BRD-A70461345 | naloxone | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
| C01718 | BRD-A70514680 | articaine | -- | -- | -- | Details |
| C01719 | BRD-A70541707 | BRD-A70541707 | -- | -- | -- | Details |
| C01720 | BRD-A70591769 | BRD-A70591769 | -- | -- | -- | Details |
| C01721 | BRD-A70633932 | BRD-A70633932 | -- | -- | -- | Details |
| C01722 | BRD-A70639593 | glycidol | -- | -- | -- | Details |
| C01723 | BRD-A70649075 | sulconazole | -- | -- | -- | Details |
| C01724 | BRD-A70731303 | BRD-A70731303 | -- | -- | avrainvillamide-analog-5 | Details |
| C01725 | BRD-A70814879 | ABC-294640 | SPHK2 | Sphingosine kinase inhibitor | -- | Details |
| C01726 | BRD-A70858459 | estramustine | -- | -- | -- | Details |
| C01727 | BRD-A70879086 | BRD-A70879086 | -- | -- | -- | Details |
| C01728 | BRD-A70931301 | BRD-A70931301 | -- | -- | -- | Details |
| C01729 | BRD-A70998768 | pinaverium | CACNA1C | T-type calcium channel blocker | -- | Details |
| C01730 | BRD-A71001587 | BRD-A71001587 | -- | -- | -- | Details |
| C01731 | BRD-A71009679 | KU-C103420N | -- | -- | -- | Details |
| C01732 | BRD-A71033472 | fendiline | -- | -- | -- | Details |
| C01733 | BRD-A71157293 | fursultiamine | -- | -- | -- | Details |
| C01734 | BRD-A71171460 | UGISS-186 | -- | -- | -- | Details |
| C01735 | BRD-A71203467 | L-stepholidine | DRD1; DRD2 | Dopamine receptor agonist; Dopamine receptor antagonist | l-stepholidine | Details |
| C01736 | BRD-A71262238 | nafadotride | DRD3 | Dopamine receptor antagonist | -- | Details |
| C01737 | BRD-A71339955 | BRD-A71339955 | -- | -- | -- | Details |
| C01738 | BRD-A71356100 | lactotensin | -- | -- | -- | Details |
| C01739 | BRD-A71390734 | idarubicin | TOP2A | Topoisomerase inhibitor | -- | Details |
| C01740 | BRD-A71459254 | cymarin | ATP1A1 | ATPase inhibitor | -- | Details |
| C01741 | BRD-A71480800 | abamectin | GABBR1; GABBR2 | GABA receptor agonist | -- | Details |
| C01742 | BRD-A71590475 | BRD-A71590475 | -- | -- | -- | Details |
| C01743 | BRD-A71657825 | BRD-A71657825 | -- | -- | 2-(biphenyl-4-ylsulfonamido)pentanedioic-acid | Details |
| C01744 | BRD-A71666580 | BRD-A71666580 | -- | -- | -- | Details |
| C01745 | BRD-A71707563 | BRD-A71707563 | -- | -- | -- | Details |
| C01746 | BRD-A71722688 | BRD-A71722688 | -- | -- | -- | Details |
| C01747 | BRD-A71725768 | metoxibutropate | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C01748 | BRD-A71765365 | mepireserpate | SLC18A1; SLC18A2 | Catecholamine depleting sympatholytic | -- | Details |
| C01749 | BRD-A71770202 | BRD-A71770202 | -- | -- | -- | Details |
| C01750 | BRD-A71774530 | lufenuron | -- | -- | -- | Details |
| C01751 | BRD-A71799696 | BH3I-1 | BCL2L1 | BCL inhibitor | -- | Details |
| C01752 | BRD-A71816415 | pravastatin | HMGCR | HMGCR inhibitor | -- | Details |
| C01753 | BRD-A71833059 | BRD-A71833059 | -- | -- | -- | Details |
| C01754 | BRD-A71880598 | BRD-A71880598 | -- | -- | -- | Details |
| C01755 | BRD-A71883111 | MH-2075 | -- | -- | -- | Details |
| C01756 | BRD-A71883286 | BRD-A71883286 | -- | -- | -- | Details |
| C01757 | BRD-A71933035 | BRD-A71933035 | -- | -- | -- | Details |
| C01758 | BRD-A71962374 | BRD-A71962374 | -- | -- | -- | Details |
| C01759 | BRD-A72024019 | tunicamycin | GNPTAB | GLCNAC phosphotransferase inhibitor | -- | Details |
| C01760 | BRD-A72066420 | mifobate | PPARG | PPAR receptor antagonist | -- | Details |
| C01761 | BRD-A72069525 | BRD-A72069525 | -- | -- | -- | Details |
| C01762 | BRD-A72075775 | iopromide | -- | -- | -- | Details |
| C01763 | BRD-A72085271 | oxiracetam | -- | -- | -- | Details |
| C01764 | BRD-A72130500 | demeclocycline | -- | -- | -- | Details |
| C01765 | BRD-A72163687 | DAC-009 | -- | -- | -- | Details |
| C01766 | BRD-A72180425 | K784-3188 | -- | -- | K-784-3188 | Details |
| C01767 | BRD-A72309220 | metergoline | HTR1A; HTR2A | Serotonin receptor antagonist; Dopamine receptor agonist | -- | Details |
| C01768 | BRD-A72322024 | APEC | -- | -- | apec | Details |
| C01769 | BRD-A72351335 | misoprostol | PTGER2; PTGER3; PTGER4 | Prostanoid receptor agonist | -- | Details |
| C01770 | BRD-A72352862 | BRD-A72352862 | -- | -- | -- | Details |
| C01771 | BRD-A72390365 | choline-alfoscerate | -- | -- | -- | Details |
| C01772 | BRD-A72441487 | stiripentol | GABRA3 | GABA uptake inhibitor | -- | Details |
| C01773 | BRD-A72483914 | spiroxatrine | HTR1A | Serotonin receptor antagonist | -- | Details |
| C01774 | BRD-A72498772 | BRD-A72498772 | -- | -- | -- | Details |
| C01775 | BRD-A72515205 | BRD-A72515205 | -- | -- | -- | Details |
| C01776 | BRD-A72538584 | valeric-acid | -- | -- | -- | Details |
| C01777 | BRD-A72575012 | BRD-A72575012 | -- | -- | -- | Details |
| C01778 | BRD-A72596465 | GW-6471 | PPARA | PPAR receptor antagonist | -- | Details |
| C01779 | BRD-A72631560 | 620_7033_4251 | -- | -- | -- | Details |
| C01780 | BRD-A72666989 | timosaponin | -- | -- | -- | Details |
| C01781 | BRD-A72703248 | SKF-96365 | CYP3A4; TRPC1 | Calcium channel blocker | -- | Details |
| C01782 | BRD-A72711497 | lasalocid | -- | -- | -- | Details |
| C01783 | BRD-A72758037 | asiatic-acid | -- | -- | -- | Details |
| C01784 | BRD-A72767275 | nalmefene | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
| C01785 | BRD-A72796238 | BRD-A72796238 | -- | -- | -- | Details |
| C01786 | BRD-A72837804 | BRD-A72837804 | -- | -- | -- | Details |
| C01787 | BRD-A72988804 | tiaprofenic-acid | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C01788 | BRD-A73119586 | BRD-A73119586 | -- | -- | -- | Details |
| C01789 | BRD-A73150064 | BRD-A73150064 | -- | -- | -- | Details |
| C01790 | BRD-A73368467 | fexofenadine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01791 | BRD-A73427433 | adaprev | M6PR | TGF beta receptor inhibitor | -- | Details |
| C01792 | BRD-A73513677 | BRD-A73513677 | -- | -- | -- | Details |
| C01793 | BRD-A73556557 | tagatose | PYGL | Phosphorylase inhibitor | -- | Details |
| C01794 | BRD-A73558769 | BRD-A73558769 | -- | -- | -- | Details |
| C01795 | BRD-A73559168 | BRD-A73559168 | -- | -- | -- | Details |
| C01796 | BRD-A73581086 | ergometrine | HTR2A | Adrenergic receptor agonist; Serotonin receptor agonist | -- | Details |
| C01797 | BRD-A73590800 | BRD-A73590800 | -- | -- | -- | Details |
| C01798 | BRD-A73594579 | BRD-A73594579 | -- | -- | -- | Details |
| C01799 | BRD-A73605923 | mocimycin | -- | -- | -- | Details |
| C01800 | BRD-A73618687 | BRD-A73618687 | -- | -- | -- | Details |
| C01801 | BRD-A73635141 | hydrocortisone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C01802 | BRD-A73635700 | BRD-A73635700 | -- | -- | -- | Details |
| C01803 | BRD-A73680854 | PT-630 | DPP4 | Dipeptidyl peptidase inhibitor | -- | Details |